Supriya Lifescience Limited
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-28
Analyst
Molecule Ventures
Equibles does not estimate personal net worth.
Khrusha Sanchaira is recorded as Analyst at Molecule Ventures. Khrusha Sanchaira has spoken on 1 earnings call across 1 company, most recently for Supriya Lifescience Limited on May 28, 2026. The companies whose calls Khrusha Sanchaira spoke on are classified in the Healthcare sector.
“So, firstly, congratulations on a good set of numbers. My first question is on the F block at our Lote Parshuram plans, which was mentioned in your presentation.”
Molecule Ventures
Analyst
Transcript header (unverified)
Supriya Lifescience Limited
Biotechnology · Healthcare
Supriya Lifescience Limited Q4 FY26 Earnings Conference Call
Supriya Lifescience Limited